Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

(2010) SHARP Collaborative Group   AMERICAN HEART JOURNAL

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis

(2009) S. Fan et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Tolerability of Sevelamer Carbonate in Hyperphosphatemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis

(2008) M. Ketteler et al.   Clinical Journal of the American Society of Nephrology

Phosphorus Binders and Survival on Hemodialysis

(2008) T. Isakova et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

(2008) P. Evenepoel et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Lanthanum Carbonate Effectively Controls Serum Phosphate Without Affecting Serum Calcium Levels in Patients Undergoing Hemodialysis

(2008) Takashi Shigematsu et al.   THERAPEUTIC APHERESIS AND DIALYSIS